Treatment Persistence of Paliperidone Palmitate 3‐Month in Patients With Schizophrenia: A Japan Medical Data Center Claims Database Analysis

Treatment Persistence of Paliperidone Palmitate 3‐Month in Patients With Schizophrenia: A Japan Medical Data Center Claims Database Analysis

ABSTRACT Aim To examine treatment persistence rates of paliperidone palmitate 3‐month (PP3M) for schizophrenia in Japan because evidence in real‐world settings is limited. Methods A retrospective population‐based cohort study was conducted using the Japan Medical Data Center claims database. The ove...

Full description

Saved in:
Bibliographic Details
Main Authors: Akihide Wakamatsu, Madoka Chinen, Hiroshi Horio, Chih‐Lin Chiang, Natsuko Tokushige, Yosuke Saga
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Neuropsychopharmacology Reports
Subjects:
database
paliperidone palmitate
persistence rate
schizophrenia
treatment switching
Online Access:https://doi.org/10.1002/npr2.70019
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items